IonQ, Inc. filings document a public quantum technology company with common stock, warrants and recurring capital-structure disclosures. Its 8-K reports include operating and financial results, material-event updates, registration rights agreements, unregistered equity issuances, resale prospectus supplements and acquisition-related share issuances, including the completed Skyloom Global acquisition.
IonQ proxy materials cover shareholder voting matters, board governance, executive compensation and pay-versus-performance disclosures. The company’s filing record also reflects material agreements, warrant and common-stock terms, financial reporting furnished with earnings releases, and governance matters connected to its quantum computing, networking, sensing, security and space-based data businesses.
IonQ Inc. filed a notice of proposed insider stock sales under Rule 144. The filing covers the planned sale of 20,000 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $1,033,400. These shares were acquired on 12/11/2025 through the cash exercise of stock options granted by the issuer. The filing also notes that total common shares outstanding are 354,279,591, providing context for the size of the planned sale.
IonQ, Inc. insider plans additional share sale under Rule 144. A holder has filed a notice to sell 73,155 shares of IonQ common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of approximately $3,772,120.53. IonQ had 354,279,591 common shares outstanding. The shares to be sold were acquired on 12/11/2025 by exercising options under a registered plan and paid for in cash on the same date.
Over the past three months, the same seller and related joint accounts have already sold several IonQ common stock blocks, including 133,615 shares on 12/09/2025 for $7,181,124.81, 100,000 shares on 11/20/2025 for $4,686,054.00, and additional smaller sales. By signing the notice, the seller represents they are not aware of undisclosed material adverse information about IonQ’s operations.
IonQ, Inc. insider plans sale of common stock under Rule 144. A person associated with IonQ has filed a notice to sell 4,490 shares of common stock through E-TRADE Financial Corporation on the NYSE, with an approximate sale date of 12/11/2025 and an aggregate market value of 236,578. The filing notes that IonQ had 354,279,591 shares of common stock outstanding.
The 4,490 shares to be sold were acquired on 12/10/2025 through the vesting of restricted stock units as equity compensation from the issuer. The notice also discloses that the same seller, identified as Paul Dacier at IonQ’s address, sold 4,175 shares of common stock on 09/11/2025 for gross proceeds of 185,376.68. By signing, the seller represents they are not aware of undisclosed material adverse information about IonQ.
IonQ filed a notice of planned stock sales under Rule 144. The filing covers the proposed sale of 15,420 shares of common stock through E-TRADE Financial Corporation on the NYSE, with an aggregate market value of 812,480. The shares are part of a much larger base of 354,279,591 shares outstanding. These shares were acquired on 12/10/2025 through the vesting of restricted stock units as equity compensation from the issuer, with the sale expected around 12/11/2025.
IonQ insider files to sell recently vested shares. A Form 144 notice discloses that an IonQ, Inc. affiliate plans to sell 17,690 shares of common stock through E-TRADE Financial Corporation on the NYSE, with an approximate sale date of 12/11/2025 and an aggregate market value of 932,086. These shares were acquired on 12/10/2025 through the vesting of restricted stock units as equity compensation from the issuer.
The filing also notes that, during the past three months, Niccolo de Masi sold 16,120 shares of IonQ common stock on 09/11/2025 for gross proceeds of 715,753.79. By signing the notice, the seller represents that they are not aware of any undisclosed material adverse information about IonQ’s current or prospective operations.
IonQ, Inc. (IONQ) received a Form 144 notice for a planned sale of 230,090 shares of its common stock through E-TRADE Financial Corporation on the NYSE, with an approximate sale date of 12/11/2025. The aggregate market value of the planned sale is stated as 12,123,442, and the number of common shares outstanding is 354,279,591.
The shares to be sold were acquired on 12/10/2025 via the vesting of restricted stock units as equity compensation from the issuer. The seller has also sold common stock of IonQ during the past three months, including 133,615 shares on 12/09/2025 for gross proceeds of 7,181,124.81 and several earlier transactions in November and September 2025.
IONQ reported a planned insider sale of company stock under Rule 144. The person filing intends to sell 24,030 shares of IONQ common stock through E-TRADE Financial Corporation on the NYSE, with an approximate sale date of 12/11/2025. The shares have an aggregate market value of 1,266,141 based on the information provided.
The 24,030 shares to be sold were acquired on 12/10/2025 through the vesting of restricted stock units as equity compensation from the issuer. The filing notes that 354,279,591 shares of common stock were outstanding, giving context for the size of this prospective sale.
IonQ had an affiliate file a notice of proposed sale of restricted stock under Rule 144. The filing covers 133,615 shares of common stock to be sold through Morgan Stanley Smith Barney LLC, with an aggregate market value of $7,181,124.81. These shares were acquired on 12/09/2025 by exercising options under a registered plan, paid for in cash on the same date. The notice states that 354,279,591 shares of common stock were outstanding.
Over the prior three months, the same or related holders sold additional IonQ common shares in several transactions, including 100,000 shares on 11/20/2025 and 19,976 shares on 09/11/2025, for total disclosed gross proceeds in the multi-million dollar range. By signing the notice, the seller represents they do not know of any material adverse information about IonQ’s operations that has not been publicly disclosed.
IonQ, Inc. disclosed the equity holdings of its Chief Business Officer in a regulatory ownership report. The executive beneficially owns 236,043 shares of common stock, held directly. This total reflects 800 shares of common stock and two restricted stock unit (RSU) awards that vest over time.
One RSU award covers 64,157 RSUs, vesting over two years, with 42,771 shares vesting on December 10, 2025 and 21,386 shares vesting on December 10, 2027, subject to continued service. A second RSU award covers 171,086 RSUs, vesting over four years, with 25% vesting on December 10, 2026 and the remainder vesting quarterly on March 10, June 10, September 10, and December 10 thereafter, also conditioned on ongoing service.
IonQ, Inc. filed an amended current report to add details of the separation agreement with its former Chief Financial Officer, Thomas Kramer. The amendment explains that, under the company’s executive severance plan and his performance-based equity award, Kramer will receive a lump-sum cash severance equal to nine months of base salary, his full 2025 target bonus and an additional pro-rated 2025 bonus for the period he worked, payable after his release of claims becomes effective.
IonQ will also cover his health insurance premiums under COBRA for up to nine months if he elects continuation coverage. All of his unvested restricted stock units and certain unvested stock options will fully vest, while remaining unvested options will be forfeited, and his performance stock units will vest at target, adjusted for the portion of the performance period he served. The amendment does not change other disclosures in the original report.